Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Leukemia - United Kingdom
doi 10.1038/s41375-020-0823-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

BCR-ABL-transformed GMP as Myeloid Leukemic Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Development of a Potent Protein Degrader Against Oncogenic BCR-ABL Protein

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2019English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy